Merit Medical Systems
Merit Medical gets FDA’s highest-risk label over Hospira injections
Zynex CEO clears out board | Personnel Moves
Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.
Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard’s vision for the rehab devices maker.
Kardiametrics sues medical device makers over blood clot patents
Special charges devour Merit Medical’s bottom line in Q2
Merit Medical Systems (NSDQ:MMSI) saw its bottom line drop dramatically during its 2nd quarter, thanks in part to some high-value temporary expenses, but the device maker’s otherwise promising financials got some attention from Wall Street last week.
Merit Medical to buy catheter maker Medigroup for an undisclosed amount
Merit Medical Systems (NSDQ:MMSI) agreed to acquire Medigroup, a peritoneal dialysis catheters manufacturer based in Illinois, for an undisclosed amount.
GPO: Novation awards new deals to medtech giants
Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Merit Medical to pay $167M for GE Healthcare’s Thomas Medical OEM vascular access biz
Merit Medical Systems (NSDQ:MMSI) agreed to pony up some $167 million for GE Healthcare‘s (NYSE:GE) Thomas Medical Products business, which makes an OEM maker of catheters used for vascular access.
Merit Medical posts record profit with a Street-beating Q3
Medical devices maker Merit Medical (NSDQ:MMSI) posted a Wall Street-beating net income for its 3rd quarter, contributing to 9-month earnings higher than the company’s ever had before.
Diabetes: U.K., China alert on blood glucose monitors | MassDevice.com On Call
MASSDEVICE ON CALL — Regulators in the U.K. and China issued public warnings about home blood glucose monitors for visually impaired patients with diabetes, warning that the devices may give false readings.
The devices, manufactured by TaiDoc Technology Corp., do not alert patients when sufficient blood has been applied to the meter, potentially providing falsely low blood glucose results if the test strips are under-filled and falsely high readings if the strips are over-filled, according to the agencies.